Analysis of FCE 23762 (methoxymorpholinodoxorubicin hydrochloride), a new antitumour agent, by HPTLC and scanning densitometry
- DOI
- 10.1016/0731-7085(93)80106-b
- Published
- 1993-01
- Container
- Journal of Pharmaceutical and Biomedical Analysis
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/0731-7085-93-80106-b,
title = {Analysis of FCE 23762 (methoxymorpholinodoxorubicin hydrochloride), a new antitumour agent, by HPTLC and scanning densitometry},
author = {A. Farina and M.G. Quaglia and A. Doldo and S. Calandra and F.R. Gallo},
year = {1993},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
doi = {10.1016/0731-7085(93)80106-b},
url = {https://doi.org/10.1016/0731-7085(93)80106-b}
}RIS
TY - JOUR TI - Analysis of FCE 23762 (methoxymorpholinodoxorubicin hydrochloride), a new antitumour agent, by HPTLC and scanning densitometry AU - A. Farina AU - M.G. Quaglia AU - A. Doldo AU - S. Calandra AU - F.R. Gallo PY - 1993 JO - Journal of Pharmaceutical and Biomedical Analysis DO - 10.1016/0731-7085(93)80106-b UR - https://doi.org/10.1016/0731-7085(93)80106-b ER -
APA
Farina, A., Quaglia, M., Doldo, A., Calandra, S., & Gallo, F. (1993). Analysis of FCE 23762 (methoxymorpholinodoxorubicin hydrochloride), a new antitumour agent, by HPTLC and scanning densitometry. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/0731-7085(93)80106-b
Source records
- crossref · retrieved 2026-11-10T19:05:45.180Z